Phase I study of PF-04691502, a small-molecule, oral, dual...

Investigational New Drugs 2014 / 06 Vol. 32; Iss. 3

Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer

Britten, Carolyn D., Adjei, Alex A., Millham, Robert, Houk, Brett E., Borzillo, Gary, Pierce, Kristen, Wainberg, Zev A., LoRusso, Patricia M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-013-0062-5
Date:
June, 2014
File:
PDF, 286 KB
english, 2014
Conversion to is in progress
Conversion to is failed